Novacyt S.A.
NCYT.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | 69.5% | -45% | -78% | – |
| Cost of Goods Sold | -£0 | £0 | £0 | £0 |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 163.4% | 32.2% | 27.3% | 31% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £0 | £0 | £0 |
| SG&A Expenses | £0 | £0 | £0 | £0 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Income | -£0 | -£0 | -£0 | -£0 |
| % Margin | -190.2% | -254.9% | -78.9% | -1.4% |
| Other Income/Exp. Net | -£0 | £0 | £0 | -£0 |
| Pre-Tax Income | -£0 | -£0 | -£0 | -£0 |
| Tax Expense | -£0 | -£0 | £0 | -£0 |
| Net Income | -£0 | -£0 | -£0 | -£0 |
| % Margin | -212.7% | -244.3% | -105.5% | -10.2% |
| EPS | -0.59 | -0.4 | -0.31 | -0.14 |
| % Growth | -47.5% | -29% | -121.4% | – |
| EPS Diluted | -0.59 | -0.4 | -0.31 | -0.14 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | -£0 | £0 | £0 | £0 |
| EBITDA | -£0 | -£0 | -£0 | -£0 |
| % Margin | -174.8% | -157.6% | -55.5% | -4.4% |